Plain-English translation of NCT04647097 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
The REAPPEAR study is testing whether a quit-smoking and quit-drinking program can help prevent acute pancreatitis from returning. You would be hospitalized with alcohol-related pancreatitis and smoke every day. The study will compare two groups: one that receives standard support to quit, and another that gets standard support plus extra help at regular check-ins over 2 years.
Doctors know that alcohol and smoking cause pancreatitis to come back and can lead to long-term damage to the pancreas, but there hasn't been strong research showing exactly how much a quit-smoking and quit-drinking program can help prevent this. This study will provide that evidence.
You likely qualify if…
You likely don't qualify if…
You will be in the study for 2 years. Before joining, you'll receive standard support to help you quit smoking and drinking. Then you'll be randomly assigned to either a standard support group or a group that also receives extra brief counseling and lab tests every 3 months. At each visit, you'll have blood pressure and weight checked, provide blood and urine samples, and answer questions about your motivation to quit, mood, quality of life, and finances. Researchers will track whether your pancreatitis returns during this time.
AI-generated summary from trial data · Oct 12, 2026 · Not medical advice
Hungary